Puma Biotechnology, Inc. (NYSE: PBYI) announced that a biomarker ... 2016 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) that is ...
News
- Puma Biotech (PBYI) Updates on PB272 NSABP FB-7 Phase 2; No Significant Difference Noted
- Texas Innovations in Health Care: More Austin biotech companies go public, but hit stock turbulence
Editor's Note: This article is part of a special series produced jointly by the Business Journals in Austin, Dallas, Houston and San Antonio, highlighting ...
- This Booming Tea Seller Has 3 Business-Building Lessons to Share
So he and his roommate, Rickey Ishida (who happened to be a biomedical engineer), began experimenting with high-caffeine tea blends to get ...
- Puma Biotechnology, Inc. (NYSE:PBYI) update interim results from Phase II clinical trial of PB272 ...
Puma Biotechnology, Inc. (NYSE:PBYI) announced that updated interim ... Symposium (SABCS) that is currently taking place in San Antonio, Texas.
- SA-based global biotech company halts plans to launch IPO
If San Antonio is going to expand its list of public companies, it's going to have to do so without Acelity LP. The global biotech company, which has its ...